Neurocognitive function and health-related quality of life in a nationwide cohort of childhood brain tumor survivors:Oral abstracts

Autor: Helligsø, Anne Sophie Lind, Henriksen, Louise Tram, Kenborg, Line, Lassen, Yasmin Alexandra, Wu, Lisa Maria, Winther, Jeanette Falck, Hasle, Henrik, Amidi , Ali

Publikováno v: Helligsø, A S L, Henriksen, L T, Kenborg, L, Lassen, Y A, Wu, L M, Winther, J F, Hasle, H & Amidi, A 2022, ' Neurocognitive function and health-related quality of life in a nationwide cohort of childhood brain tumor survivors : Oral abstracts ', Pediatric Blood & Cancer, vol. 69, no. S5 . https://doi.org/10.1002/pbc.29952

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::65c4aa8f4896a8903832e12c2a65f8b1
https://pure.au.dk/portal/da/publications/neurocognitive-function-and-healthrelated-quality-of-life-in-a-nationwide-cohort-of-childhood-brain-tumor-survivors(80215f81-fb2d-4f55-b42d-e613e9e9efea).html

Abstract CT103: Final results for OptimalTTF-1: Optimizing Tumor Treating Fields with targeted skull remodeling surgery for first recurrence glioblastoma: Phase 1 trial:In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA)

Autor: Mikic, Nikola, Korshoej, Anders Rosendal, Lukacova, Slávka, Sørensen, Jens Christian Hedemann, Lundgaard Hansen, Frederik, Thielscher, Axel, Cortnum, Søren, Guldberg, Trine Lignell, Lassen, Yasmin Alexandra, Rahbek, Christian, Severinsen, Kåre, Oettingen, Gorm von

Publikováno v: Mikic, N, Korshoej, A R, Lukacova, S, Sørensen, J C H, Lundgaard Hansen, F, Thielscher, A, Cortnum, S, Guldberg, T L, Lassen, Y A, Rahbek, C, Severinsen, K & Oettingen, G V 2020, ' Abstract CT103: Final results for OptimalTTF-1: Optimizing Tumor Treating Fields with targeted skull remodeling surgery for first recurrence glioblastoma: Phase 1 trial : In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): ', Cancer Research, vol. 80, no. 16, suppl., CT103 . https://doi.org/10.1158/1538-7445.AM2020-CT103

We present a clinical open label, phase-1 trial (OptimalTTF-1, NCT02893137), which aims to test a novel treatment for first recurrence glioblastoma (rGBM). The aim of the treatment is to optimize the electric field generated by Tumor Treating Fields

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::d16218cc7f1aa34bce96d1f698c35fa0
https://pure.au.dk/portal/da/publications/abstract-ct103-final-results-for-optimalttf1-optimizing-tumor-treating-fields-with-targeted-skull-remodeling-surgery-for-first-recurrence-glioblastoma-phase-1-trial(1d935bc9-b466-4549-9b5c-a8d8754497f1).html

Non-invasive assessment of Isocitrate dehydrogenase (IDH) mutational status in cerebral gliomas by Magnetic Resonance Spectroscopy in a clinical setting

Autor: Tietze, Anna, Choi, Changho, Mickey, Bruce, Maher, Elizabeth, Ulhøi, Benedicte Parm, Sangill, Ryan, Lassen, Yasmin Alexandra, Lukácová, Slávka, Østergaard, Leif, Oettingen, Gorm von

Publikováno v: Tietze, A, Choi, C, Mickey, B, Maher, E, Ulhøi, B P, Sangill, R, Lassen, Y A, Lukácová, S, Østergaard, L & Oettingen, G V 2017, ' Non-invasive assessment of Isocitrate dehydrogenase (IDH) mutational status in cerebral gliomas by Magnetic Resonance Spectroscopy in a clinical setting ', Journal of Neurosurgery .

Background: Mutations in the Isocitrate Dehydrogenase (IDH) gene are of proven diagnostic and prognostic significance for cerebral gliomas. We evaluated the clinical feasibility of using a recently described method for determining IDH mutational stat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::97fa95f1f9a1db96531481f242bcf9a0
https://pure.au.dk/portal/da/publications/noninvasive-assessment-of-isocitrate-dehydrogenase-idh-mutational-status-in-cerebral-gliomas-by-magnetic-resonance-spectroscopy-in-a-clinical-setting(2e557ecb-646e-4d89-be01-0e808093c75f).html